These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38135060)

  • 1. Update on immunohistochemistry in bone and soft tissue tumors: Cost-effectively replacing molecular testing with immunohistochemistry.
    Wakefield C; Hornick JL
    Hum Pathol; 2024 May; 147():58-71. PubMed ID: 38135060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Immunohistochemistry for Soft Tissue and Bone Tumors: An Update.
    Schaefer IM; Hornick JL
    Adv Anat Pathol; 2018 Nov; 25(6):400-412. PubMed ID: 30134255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors.
    Choi JH; Ro JY
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent updates in the diagnosis of soft tissue tumors: Newly described tumor entities, newer immunohistochemical and genetic markers, concepts, including "inter-tumor relationships".
    Rekhi B
    Indian J Pathol Microbiol; 2021; 64(3):448-459. PubMed ID: 34341252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft tissue tumor pathology: New diagnostic immunohistochemical markers.
    Doyle LA
    Semin Diagn Pathol; 2015 Sep; 32(5):370-80. PubMed ID: 25726492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back to the future! Selected bone and soft tissue neoplasms with shared genetic alterations but differing morphological and immunohistochemical phenotypes.
    Dashti NK; Schukow CP; Kilpatrick SE
    Hum Pathol; 2024 May; 147():129-138. PubMed ID: 38521373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathologic diagnosis of bone and soft tissue tumors: update].
    Nojima T
    Rinsho Byori; 2014 Jun; 62(6):578-85. PubMed ID: 25151777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Molecular and Immunohistochemical Adjunct Modalities in the Diagnosis of Soft Tissue Neoplasms.
    Mourtzoukou D; Fisher C; Thway K
    Int J Surg Pathol; 2015 Dec; 23(8):601-8. PubMed ID: 26310271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
    Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
    Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular biology for sarcoma: useful or necessary?].
    Neuville A; Coindre JM; Chibon F
    Ann Pathol; 2015 Jan; 35(1):107-13. PubMed ID: 25533919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update.
    Patrichi AI; Gurzu S
    Pathol Res Pract; 2024 Aug; 260():155406. PubMed ID: 38878666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on WHO classification for small round cell tumors: Ewing sarcoma vs. everything else.
    Dehner CA; Lazar AJ; Chrisinger JSA
    Hum Pathol; 2024 May; 147():101-113. PubMed ID: 38280658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.
    Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR
    Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors.
    Bridge JA
    Mod Pathol; 2014 Jan; 27 Suppl 1():S80-97. PubMed ID: 24384855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft Tissue Fine-Needle Aspiration: Current and Future Impact on Patient Care.
    Lajara S; Jo VY
    Surg Pathol Clin; 2024 Sep; 17(3):483-507. PubMed ID: 39129144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary value of molecular analysis to expert review in refining classification of uncommon soft tissue tumors.
    Suurmeijer AJH; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23196. PubMed ID: 37702439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Brief Overview and Update on Major Molecular Genomic Alterations in Solid, Bone and Soft Tissue Tumors, and Hematopoietic As Well As Lymphoid Malignancies.
    Zhang W; Yao J; Zhong M; Zhang Y; Guo X; Wang HY
    Arch Pathol Lab Med; 2021 Nov; 145(11):1358-1366. PubMed ID: 34270703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Entities and New Diagnostic Markers for Head and Neck Soft Tissue and Bone Tumors.
    Franchi A; Thompson LDR; Hernandez-Prera JC; Agaimy A; Williams MD; Mikkelsen LH; Bishop JA; Willems SM; Hellquist H; Ferlito A
    Adv Anat Pathol; 2021 May; 28(3):139-149. PubMed ID: 33559990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical correlates of recurrent genetic alterations in sarcomas.
    Anderson WJ; Hornick JL
    Genes Chromosomes Cancer; 2019 Feb; 58(2):111-123. PubMed ID: 30382607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
    Szurian K; Kashofer K; Liegl-Atzwanger B
    Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.